GE HealthCare Technologies (GEHC)
Health Care4 articles
Price chart
GE HealthCare Technologies (GEHC) overview
GE HealthCare makes medical-imaging and diagnostic equipment. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
GE HealthCare Technologies trades on the NasdaqGS under the ticker symbol GEHC. As of the most recent market data, the stock was priced around $63.07, down 4.00% on the session, giving GE HealthCare Technologies a market capitalization of roughly $28.69B.
Over the past 52 weeks, GEHC has traded between $58.75 and $89.77. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 15.8, a common gauge of how richly the market prices the company's earnings. GE HealthCare Technologies also pays a dividend, currently yielding around 21.00%.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch GEHC
As one of the larger companies in the Health Care sector, GE HealthCare Technologies is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch GEHC for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest GEHC news
GE Healthcare (GEHC) CFO Purchases $200,585 in Company Stock
James Saccaro, CFO of GE Healthcare (GEHC), purchased $200,585 worth of company stock. This transaction highlights insider confidence in the company’s future performance. Insider buying can be an indication of positive sentiment regarding future stock movements, which may influence investor perception. The purchase took place at a time when GEHC's stock price is subject to market fluctuations, making such insider activity notable for potential investors.
Read More: GE Healthcare (GEHC) CFO Purchases $200,585 in Company Stock
GEHC Reports Q1 2026 Revenue of $5.1 Billion with 2.9% Growth
GE HealthCare Technologies (GEHC) reported Q1 2026 revenue of $5.1 billion, reflecting a 2.9% organic growth year over year. The company noted a record backlog of $21.8 billion and a book-to-bill ratio of 1.07x. However, management reduced full-year profit guidance due to $250 million in gross inflation and a supplier-related recall, adjusting EPS to between $4.80 and $5.00 while projecting free cash flow of approximately $1.6 billion. Additionally, revenue increased in EMEA and other regions, but U.S. growth experienced mid-single digits, and China revenue improved sequentially despite a year-over-year decline.
Read More: GEHC Reports Q1 2026 Revenue of $5.1 Billion with 2.9% Growth
Terri A. Sewell Sells Stake in GE Healthcare (GEHC) and Tapestry (TPR)
Representative Terri A. Sewell reported the sale of stocks in GE Healthcare Technologies (GEHC) and Tapestry (TPR). The disclosed transactions included selling a total of approximately 1,500 shares of GEHC and 3,000 shares of TPR. The sales were registered as part of routine portfolio management. Investor reaction may be influenced by these moves as they could signal a shift in confidence regarding the future performance of these companies.
Read More: Terri A. Sewell Sells Stake in GE Healthcare (GEHC) and Tapestry (TPR)
GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CT
On March 23, 2026, GE HealthCare Technologies Inc. (GEHC) obtained FDA 510(k) clearance for its Photonova Spectra, a next-generation photon-counting CT system. This system features Deep Silicon detector technology, which provides higher spatial and spectral resolution compared to conventional models. It can process data volumes up to 50 times greater than standard CT systems, supporting efficient workflows. Following this clearance, GEHC is preparing for full commercial availability in the U.S. market, addressing the increasing diagnostic demand.
Read More: GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CTMore Health Care stocks
Frequently asked questions
Is GE HealthCare Technologies in the S&P 500?
Yes. GE HealthCare Technologies (GEHC) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is GEHC in?
GE HealthCare Technologies is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest GEHC news?
This page collects recent GE HealthCare Technologies (GEHC) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is GE HealthCare Technologies's stock price?
As of the most recent market data, GE HealthCare Technologies (GEHC) traded at approximately $63.07. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is GE HealthCare Technologies's market cap?
GE HealthCare Technologies has a market capitalization of roughly $28.69B, based on its most recent share price and shares outstanding.
What is GEHC's P/E ratio?
GEHC trades at a trailing price-to-earnings ratio of about 15.8. The P/E ratio compares a company's share price to its earnings per share.